Literature DB >> 6392101

Toxoplasmosis in immunosuppression and AIDS.

B Velimirovic.   

Abstract

Reactivation of chronic, latent infection of Toxoplasma gondii has been observed previously in transplant patients and malignancies treated with immunosuppressive drugs. Recently it has emerged as the most common recognized central nervous system infection in acquired immunodeficiency syndrome (AIDS) patients, seen in 6-20% of all AIDS cases. It produces diffuse encephalopathy or space-occupying and necrotic lesions. Contrary to classical toxoplasmosis, the serological diagnosis is unreliable and the therapeutical response in most cases is poor.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6392101     DOI: 10.1007/BF01651143

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  17 in total

1.  Hazard of folinic acid with pyrimethamine and sulfadiazine.

Authors:  R E Helmer
Journal:  Ann Intern Med       Date:  1975-01       Impact factor: 25.391

2.  Toxoplasmosis complicating malignancy. Experience at the National Cancer Institute.

Authors:  W M Vietzke; A H Gelderman; P M Grimley; M P Valsamis
Journal:  Cancer       Date:  1968-05       Impact factor: 6.860

3.  Toxoplasmosis. Clinical experiences in a cancer hospital.

Authors:  R M Carey; A C Kimball; D Armstrong; P H Lieberman
Journal:  Am J Med       Date:  1973-01       Impact factor: 4.965

4.  Outbreak of central-nervous-system toxoplasmosis in western Europe and North America.

Authors:  B J Luft; F Conley; J S Remington; M Laverdiere; K F Wagner; J F Levine; P C Craven; D A Strandberg; T M File; N Rice; F Meunier-Carpentier
Journal:  Lancet       Date:  1983-04-09       Impact factor: 79.321

5.  Agglutination test for diagnosis of toxoplasmosis in AIDS.

Authors:  R E McCabe; D Gibbons; R G Brooks; B J Luft; J S Remington
Journal:  Lancet       Date:  1983-09-17       Impact factor: 79.321

6.  Acquired toxoplasmosis. A neglected cause of treatable nervous system disease.

Authors:  J J Townsend; J S Wolinsky; J R Baringer; P C Johnson
Journal:  Arch Neurol       Date:  1975-05

7.  Acquired immunodeficiency syndrome in African patients.

Authors:  N Clumeck; J Sonnet; H Taelman; F Mascart-Lemone; M De Bruyere; P Vandeperre; J Dasnoy; L Marcelis; M Lamy; C Jonas
Journal:  N Engl J Med       Date:  1984-02-23       Impact factor: 91.245

8.  Serologic diagnosis of active toxoplasmosis complicating malignant diseases. Usefulness of IgM antibodies and gel-diffusion.

Authors:  M N Lunde; A H Gelderman; S L Hayes; C L Vogel
Journal:  Cancer       Date:  1970-03       Impact factor: 6.860

9.  Central-nervous-system toxoplasmosis in homosexual men and parenteral drug abusers.

Authors:  B Wong; J W Gold; A E Brown; M Lange; R Fried; M Grieco; D Mildvan; J Giron; M L Tapper; C W Lerner
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

10.  Toxoplasma gondii and cytomegalovirus: mixed infection by a parasite and a virus.

Authors:  A H Gelderman; P M Grimley; M N Lunde; A S Rabson
Journal:  Science       Date:  1968-06-07       Impact factor: 47.728

View more
  8 in total

1.  The changing pattern of human immunodeficiency virus-associated cerebral toxoplasmosis: a study of 46 postmortem cases.

Authors:  C Strittmatter; W Lang; O D Wiestler; P Kleihues
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Isolation of Toxoplasma gondii from immunocompromised patients using tissue culture.

Authors:  I Calicó; E Caballero; O Martinez; L Arcalís Arce; L Llopart; I Ocaña; C Juste
Journal:  Infection       Date:  1991 Sep-Oct       Impact factor: 3.553

3.  Toxoplasma gondii: differentiation and death of bradyzoites.

Authors:  C E Pavesio; M L Chiappino; P Y Setzer; B A Nichols
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

4.  Endocytosis at the micropore of Toxoplasma gondii.

Authors:  B A Nichols; M L Chiappino; C E Pavesio
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

5.  Detection of toxoplasmosis in patients with end-stage renal disease by enzyme-linked immunosorbent assay and polymerase chain reaction methods.

Authors:  J Saki; S Khademvatan; S Soltani; H Shahbazian
Journal:  Parasitol Res       Date:  2012-09-20       Impact factor: 2.289

Review 6.  Neurological complications in AIDS.

Authors:  P A Fischer; W Enzensberger
Journal:  J Neurol       Date:  1987-06       Impact factor: 4.849

7.  Detection of Toxoplasma gondii by PCR and mouse bioassay in rodents of Ahvaz district, southwestern Iran.

Authors:  J Saki; S Khademvatan
Journal:  Biomed Res Int       Date:  2014-01-29       Impact factor: 3.411

8.  Malassezia and Parkinson's Disease.

Authors:  Martin Laurence; Julián Benito-León; Frédéric Calon
Journal:  Front Neurol       Date:  2019-07-24       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.